122 related articles for article (PubMed ID: 24123755)
1. Soluble CD23 measurement by CBA: A convenient and reliable quantification method in Chronic Lymphocytic Leukemia.
Grelier A; Garff-Tavernier ML; Nauwelaers F; Sarfati M; Merle-Beral H
Cytometry B Clin Cytom; 2013 Oct; ():. PubMed ID: 24123755
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD23 measurement by CBA: a convenient and reliable quantification method in chronic lymphocytic leukemia.
Grelier A; Le Garff-Tavernier M; Nauwelaers F; Sarfati M; Merle-Beral H
Cytometry B Clin Cytom; 2014 Mar; 86(2):91-7. PubMed ID: 24150841
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
Reinisch W; Willheim M; Hilgarth M; Gasché C; Mader R; Szepfalusi S; Steger G; Berger R; Lechner K; Boltz-Nitulescu G
J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
[TBL] [Abstract][Full Text] [Related]
4. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.
Molica S; Levato D; Dell'Olio M; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
Haematologica; 1996; 81(5):428-33. PubMed ID: 8952156
[TBL] [Abstract][Full Text] [Related]
5. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.
Sarfati M; Chevret S; Chastang C; Biron G; Stryckmans P; Delespesse G; Binet JL; Merle-Beral H; Bron D
Blood; 1996 Dec; 88(11):4259-64. PubMed ID: 8943862
[TBL] [Abstract][Full Text] [Related]
6. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
[TBL] [Abstract][Full Text] [Related]
8. Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia.
Piñeyroa JA; Magnano L; Rivero A; Rivas-Delgado A; Nadeu F; Correa JG; Giné E; Villamor N; Filella X; Colomer D; López M; López-Oreja I; Costa D; Aymerich M; Beà S; López-Guillermo A; Campo E; Delgado J; Mozas P
Hematol Oncol; 2022 Oct; 40(4):588-595. PubMed ID: 35611996
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of CD23 antigen in normal individuals and patients with chronic lymphocytic leukaemia (CLL).
Ling NR; Stevenson FK; Brown B
Clin Exp Immunol; 1991 Dec; 86(3):360-6. PubMed ID: 1721010
[TBL] [Abstract][Full Text] [Related]
10. The role of soluble CD23 in distinguishing stable and progressive forms of B-chronic lymphocytic leukemia.
Schwarzmeier JD; Shehata M; Hilgarth M; Marschitz I; Louda N; Hubmann R; Greil R
Leuk Lymphoma; 2002 Mar; 43(3):549-54. PubMed ID: 12002758
[TBL] [Abstract][Full Text] [Related]
11. Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta2-microglobulin in B-cell chronic lymphocytic leukemia.
Molica S; Levato D; Cascavilla N; Levato L; Musto P
Eur J Haematol; 1999 Feb; 62(2):117-22. PubMed ID: 10052715
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of soluble CD23, but not soluble CD25, predict disease progression in early stage B-cell chronic lymphocytic leukemia.
Knauf WU; Langenmayer I; Ehlers B; Mohr B; Adorf D; Nerl CH; Hallek M; Zwingers TH; Emmerich B; Thiel E
Leuk Lymphoma; 1997 Nov; 27(5-6):523-32. PubMed ID: 9477135
[TBL] [Abstract][Full Text] [Related]
13. Effects of alpha-interferon and steroids on CD23 expression and release in B-cell chronic lymphocytic leukemia.
Pozzato G; de Paoli P; Franzin F; Tulissi P; Moretti M; Basaglia G; Santini GF
Haematologica; 1994; 79(3):205-12. PubMed ID: 7926968
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble CD23 levels and CD23 expression on peripheral blood mononuclear cells in juvenile chronic arthritis.
Massa M; Pignatti P; Oliveri M; De Amici M; De Benedetti F; Martini A
Clin Exp Rheumatol; 1998; 16(5):611-6. PubMed ID: 9779313
[TBL] [Abstract][Full Text] [Related]
15. Proliferative response of B chronic lymphocytic leukemia lymphocytes stimulated with IL2 and soluble CD23.
Brizard A; Morel F; Lecron JC; Dreyfus B; Brizard F; Barra A; Preud'homme JL
Leuk Lymphoma; 1994 Jul; 14(3-4):311-8. PubMed ID: 7950920
[TBL] [Abstract][Full Text] [Related]
16. Soluble Fc epsilon RII/CD23 in patients with autoimmune diseases and Epstein-Barr virus-related disorders: analysis by ELISA for soluble Fc epsilon RII/CD23.
Yoshikawa T; Nanba T; Kato H; Hori K; Inamoto T; Kumagai S; Yodoi J
Immunomethods; 1994 Feb; 4(1):65-71. PubMed ID: 8069529
[TBL] [Abstract][Full Text] [Related]
17. Serum soluble CD23 in patients with hypogammaglobulinaemia.
Bansal AS; Haeney MR; Cochrane S; Pumphrey RS; Green LM; Bhavnani M; Wilson PB
Clin Exp Immunol; 1994 Aug; 97(2):239-41. PubMed ID: 8050171
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of apoptosis in a human pre-B-cell line by CD23 is mediated via a novel receptor.
White LJ; Ozanne BW; Graber P; Aubry JP; Bonnefoy JY; Cushley W
Blood; 1997 Jul; 90(1):234-43. PubMed ID: 9207458
[TBL] [Abstract][Full Text] [Related]
20. Regulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemia.
Schwarzmeier JD; Hubmann R; Düchler M; Jäger U; Shehata M
Leuk Lymphoma; 2005 Feb; 46(2):157-65. PubMed ID: 15621797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]